Experimental Pill Nearly Doubles Survival in Pancreatic Cancer
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
This piece identifies funds with the highest management charges in the Dividend Aristocrats group and explains potential impact on performance.
26,423 articlesA late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
A celebrity's personal choice becomes a practical blueprint for money matters. This article explores how quitting a c...
SpaceX reveals a trillion-dollar revenue forecast, a target far beyond Wall Street estimates and a test of Musk's mos...
When a star turns a festival stage into a PR moment, money follows — but so do lessons in budgeting and branding. Thi...
As cost controls tighten, doctors and AI are pressing to restore clinician-led care. Investors are watching insurers’...
RLUSD activity is rising in enterprise payments, fueling a debate about whether ripple’s rlusd replacing xrp? is poss...
Hyperliquid Strategies’ billion hype treasury trade moves into public markets, as liquidity remains untested and inve...
Palantir Technologies has had a wild ride. If you’re wondering should palantir technologies stock be bought under $14...
Headlines often shout about big investors like Vanguard piling into small stocks. But the reality behind Vanguard Ow...
In a surprising turn, anthropic’s claude overtakes chatgpt on the App Store as users rally against OpenAI. The move c...
The United States plans to deploy Merops, an AI-powered anti-drone system, to the Middle East to counter Iranian Shah...
The push to lower the bar for running Ethereum nodes is gaining momentum. This piece explores Vitalik Buterin's call ...